SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-24-005374
Filing Date
2024-01-22
Accepted
2024-01-22 17:27:58
Documents
14

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS f424b30124_phoenix.htm 424B3 16910162
2 GRAPHIC tbarchart_001.jpg GRAPHIC 230395
3 GRAPHIC timage_001.jpg GRAPHIC 141728
4 GRAPHIC timage_002.jpg GRAPHIC 110756
5 GRAPHIC timage_003.jpg GRAPHIC 397561
6 GRAPHIC timage_004.jpg GRAPHIC 108424
7 GRAPHIC timage_005.jpg GRAPHIC 530583
8 GRAPHIC timage_006.jpg GRAPHIC 254992
9 GRAPHIC timage_007.jpg GRAPHIC 477122
10 GRAPHIC tlinechart_001.jpg GRAPHIC 282487
11 GRAPHIC tlinechart_002.jpg GRAPHIC 623902
12 GRAPHIC timage_008.jpg GRAPHIC 177991
13 GRAPHIC timage_009.jpg GRAPHIC 242414
14 GRAPHIC timage_010.jpg GRAPHIC 265141
  Complete submission text file 0001213900-24-005374.txt   22206771
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-272467 | Film No.: 24549912
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)